Last updated on September 2017

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix During Pregnancy or Immediately Post-delivery


Brief description of study

The purpose of this study is to assess the immunogenicity and safety of the Infanrix hexa booster dose given at 11-18 months of age to infants who received primary vaccination at 6-14 weeks. All infants in this booster study were born to pregnant women who participated in the study 116945 [DTPA (BOOSTRIX)-047] and having received the full primary vaccination series as per protocol requirement in study 201330 [DTPA (BOOSTRIX)-048.

Clinical Study Identifier: NCT02853929

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

US GSK Clinical Trials Call ...

GSK Investigational Site
Carlton, Australia
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Calgary, AB Canada
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Halifax, NS Canada
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Montreal, QC Canada
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Brno, Czechia
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Hradec Kralove, Czechia
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Ostrava - Vitkovice, Czechia
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Praha, Czechia
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Málaga, Spain
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Antequera/Málaga, Spain
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Aravaca, Spain
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Burgos, Spain
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Madrid, Spain
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Majadahonda (Madrid), Spain
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Móstoles, Spain
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Santiago de Compostela, Spain
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Sevilla, Spain
  Connect »